Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy ; volume:43 ; number:4 ; day:15 ; month:2 ; year:2024 ; pages:723-734 ; date:4.2024
European journal of clinical microbiology & infectious diseases ; 43, Heft 4 (15.2.2024), 723-734, 4.2024
- Urheber
-
Feuth, Eeva
Nieminen, Valtteri
Palomäki, Antti
Ranti, Juha
Sucksdorff, Marcus
Finnilä, Taru
Oksi, Jarmo
Vuorinen, Tytti
Feuth, Thijs
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10096-024-04776-0
- URN
-
urn:nbn:de:101:1-2406121204463.835565847043
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Feuth, Eeva
- Nieminen, Valtteri
- Palomäki, Antti
- Ranti, Juha
- Sucksdorff, Marcus
- Finnilä, Taru
- Oksi, Jarmo
- Vuorinen, Tytti
- Feuth, Thijs
- SpringerLink (Online service)
Ähnliche Objekte (12)
Novel CD20 monoclonal antibodies for lymphoma therapy
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment
Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scidmice
The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody
Successful treatment of prolonged COVID-19 with Bamlanivimab in a patient with severe B-Cell aplasia due to treatment with an anti-CD20 monoclonal antibody : A case report
Prolonged viral suppression with anti-HIV-1 antibody therapy
Novel CD20 monoclonal antibodies for lymphoma therapy
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment
Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scidmice
The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody
Successful treatment of prolonged COVID-19 with Bamlanivimab in a patient with severe B-Cell aplasia due to treatment with an anti-CD20 monoclonal antibody : A case report
Prolonged viral suppression with anti-HIV-1 antibody therapy
Novel CD20 monoclonal antibodies for lymphoma therapy
Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment
A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
Plitidepsin as a successful rescue treatment for prolonged viral SARS-CoV-2 replication in a patient with previous anti-CD20 monoclonal antibody-mediated B cell depletion and chronic lymphocytic leukemia
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatment
Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scidmice
The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody
Successful treatment of prolonged COVID-19 with Bamlanivimab in a patient with severe B-Cell aplasia due to treatment with an anti-CD20 monoclonal antibody : A case report